‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’

Scientists found that after 18 months the drug slowed the disease progression by 27% compared with those taking the placebo.

A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease.

Lecanemab was found to slow decline in participants’ memory and thinking.